Emavusertib (tosylate)
Emavusertib tosylate (CA-4948 tosylate) is the tosylate salt form of Emavusertib. Emavusertib tosylate is an orally active inhibitor for IRAK4 (IC50=57 nM) and FLT3. Emavusertib tosylate inhibits NF-κB and MyD88 signaling pathways, reduces the generation of pro-inflammatory cytokines like IL-6 and IL-10, thereby exhibiting anti-inflammatory and anti-proliferative activities against cancer cells, leading to cell apoptosis. Emavusertib tosylate exhibits antitumor activity in mouse model[1][2][3].
Product Specifications
CAS Number
2376399-41-4
Product Name Alternative
CA-4948 (tosylate)
UNSPSC
12352005
Target
Apoptosis; FLT3; IRAK; MyD88; NF-κB
Related Pathways
Apoptosis; Immunology/Inflammation; NF-κB; Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=S(O)(C1=CC=C(C=C1)C)=O.O=C(C2=COC(C3=CC=NC(C)=C3)=N2)NC4=C(N5CC[C@H](C5)O)N=C6C(OC(N7CCOCC7)=N6)=C4
Molecular Formula
C31H33N7O8S
Molecular Weight
663.70
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD45RO (UCHL-1), CF488A conjugate, 0.1mg/mL
Fibronectin (HFN7.1), CF405S conjugate, 0.1mg/mL
